ML: Early Breast Cancer Diagnosis

Breast cancer is the most common malignancy among women worldwide, often characterized by the uncontrolled proliferation of breast cells, leading to the formation of lumps or tumors that can be detected through medical imaging such as X-rays. Distinguishing between benign and malignant tumors presen...

Full description

Saved in:
Bibliographic Details
Published in:Current problems in cancer. Case reports Vol. 13; p. 100278
Main Authors: Malakouti, Seyed Matin, Menhaj, Mohammad Bagher, Suratgar, Amir Abolfazl
Format: Journal Article
Language:English
Published: Elsevier Inc 01.03.2024
Elsevier
Subjects:
Breast cancer
Grid search
Hematology, Oncology, and Palliative Medicine
Machine learning methods
Women worldwide
Grid search
Women worldwide
Breast cancer
Machine learning methods
machine learning methods
women worldwide
Grid Search
ISSN:2666-6219, 2666-6219
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Breast cancer is the most common malignancy among women worldwide, often characterized by the uncontrolled proliferation of breast cells, leading to the formation of lumps or tumors that can be detected through medical imaging such as X-rays. Distinguishing between benign and malignant tumors presents a significant challenge in the diagnosis of breast cancer. In this study, machine learning methods, including Logistic Regression, Gradient Boosting, Ada Boost, Random Forest, and Gaussian NB with Grid Search, were employed to differentiate between healthy individuals and those with malignancies. The results revealed that the Random Forest algorithm exhibited the highest performance in predicting breast cancer, accurately identifying 99 % of both healthy and affected individuals. Additionally, both Gradient Boosting and Ada Boost demonstrated a similar level of accuracy, correctly distinguishing 98 % of healthy and affected individuals. Conversely, Gaussian NB performed the least effectively, with an accuracy of 91 % in differentiating between healthy and affected individuals, highlighting its comparatively lower predictive capability for breast cancer.
ISSN:2666-6219
2666-6219
DOI:10.1016/j.cpccr.2024.100278